Lettter to editor.png Pixabay image

Today more than 7 million Americans are living with Alzheimer’s—a number expected to increase to nearly 13 million by 2050, including 22,300 Delawareans. Without medical breakthroughs, this number is projected to rise. 

As a care partner to my husband, Tony, who is living with mild cognitive impairment, I understand firsthand the impact of this disease. Tony is receiving monthly infusions of an FDA-approved monoclonal antibody treatment to slow progression of the disease—an advancement made possible because of research funding. 

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.